RSSCategory: Prostate Cancer

U.S. cancer deaths continue long-term decline

U.S. cancer deaths continue long-term decline

Overall death rates from cancer declined from 2000 through 2009 in the United States, maintaining a trend seen since the early 1990s. Among men, the overall rate of cancer incidence fell by an average of 0.6 percent annually from 2000 through 2009. Cancer incidence rates were stable among women during the same time period and rose by 0.6 percent per year among children.

Share
January 9, 2013 | By | Reply More
A glimpse into future of cancer screening

A glimpse into future of cancer screening

Ask experts to predict the future of cancer screening, and you’ll get a range of answers. But all would agree that we need better ways to detect cancers early in the course of disease, and these new tools should improve on the benefits of screening while limiting the harms.

Share
December 26, 2012 | By | Reply More
Prostate Cancer: Facts and fiction

Prostate Cancer: Facts and fiction

When it comes to prostate cancer, there’s a lot of confusion about how to prevent it, find it early and the best way – or even whether – to treat it. Here two scientists at Fred Hutchinson Cancer Research Center to help men separate fact from fiction.

Share
August 24, 2012 | By | Reply More
You’ve been treated for cancer — now what?

You’ve been treated for cancer — now what?

What do you do when you’ve finished treatment?How do you coordinate your ongoing care with your primary care doc? How do you keep track of your medical records and get the right information to the right people about what you’ve been through? Gilda’s Club has some answers.

Share
June 14, 2012 | By | Reply More
U.S. cancer deaths continue steady decline

U.S. cancer deaths continue steady decline

Deaths from cancer in the U.S. declined from 1999 to 2008, maintaining a trend seen since the early 1990s. Mortality fell for most cancer types, including the four most common types of cancer in the United States — lung, colorectal, breast, and prostate –, although the rate of decline varied by cancer type and across racial and ethnic groups.

Share
April 5, 2012 | By | Reply More
Annual prostate screening does not reduce risk of death – study

Annual prostate screening does not reduce risk of death – study

Men who underwent annual prostate cancer screening with prostate-specific antigen testing and digital rectal examination had a 12 percent higher incidence of prostate cancer than men in the control group but the same rate of death from the disease.

Share
January 23, 2012 | By | Reply More
Prostate cancer screening test should not be routine — panel

Prostate cancer screening test should not be routine — panel

The influential U.S. Preventive Services Task Force finds that routine PSA testing does men more harm than good.

Share
October 7, 2011 | By | 1 Reply More
Do the elderly get too many medical tests?

Do the elderly get too many medical tests?

Are older patients being over tested? There is little evidence the elderly benefit from colon, breast and prostate cancer screening — and considerable risk.

Share
September 13, 2011 | By | Reply More
Tracking the rise of robotic surgery for prostate cancer

Tracking the rise of robotic surgery for prostate cancer

Robotic prostatectomy proliferated quickly, but what it means for patients and the health care system, is still a matter of study and debate.

Share
August 13, 2011 | By | Reply More
Watchful waiting: When treatment can wait

Watchful waiting: When treatment can wait

Sometimes, delaying treatment while regularly monitoring the progress of a disease — a strategy called “watchful waiting” — may be better than starting treatment right away.

Share
June 1, 2011 | By | Reply More
Doctors dispute benefits of early diagnosis

Doctors dispute benefits of early diagnosis

Screening tests that diagnose illnesses early may actually cause more harm than good, a team of Dartmouth medical researchers argue in a new book. Michelle Andrews interview the authors.

Share
February 8, 2011 | By | Reply More
Men with low-risk prostate cancer usually get treatment, despite side effects

Men with low-risk prostate cancer usually get treatment, despite side effects

For men with prostate cancer that grows slowly, the treatments may cause more harm than good.

Share
July 27, 2010 | By | Reply More
FDA approves Dendreon’s prostate cancer treatment

FDA approves Dendreon’s prostate cancer treatment

The treatment is an novel immune therapy in which a patient’s immune cells are stimulated to attack prostate cancer cells more aggressively.

Share
April 29, 2010 | By | 1 Reply More
Health stories in the news

Health stories in the news

FDA weighs Seattle company’s cancer vaccine. Officials investigate reports of H1N1 vaccine side effects. Con artists take advantage of confusion over health reform.

Share
April 25, 2010 | By | Reply More
Evidence-Based Medicine: Hard For Some To Swallow

Evidence-Based Medicine: Hard For Some To Swallow

People don’t always want to do what the data say to do.

Share
November 22, 2009 | By | Reply More